Evidence map›Paper›PMID 26564535›Full record

ReviewThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2015

Counting children with tuberculosis: why numbers matter.

J A Seddon, H E Jenkins, L Liu, T Cohen, R E Black, T Vos, M C Becerra, S M Graham, C Sismanidis, P J Dodd

Abstract readReview
In one paragraph

Review in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Tuberculosis challenges: Resistance, co-infection, diagnosis, and treatment.European journal of microbiology & immunology · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

J A SeddonDepartment of Paediatrics, Imperial College London, London, UK.
H E JenkinsDepartment of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts.
L LiuInstitute for International Programs, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
T CohenDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut.
R E BlackInstitute for International Programs, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
T VosInstitute for Health Metrics and Evaluation, University of Washington, Seattle, Washington.
M C BecerraDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.
S M GrahamCentre for International Child Health, University of Melbourne Department of Paediatrics and Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Victoria, Australia.
C SismanidisGlobal TB Programme, World Health Organization, Geneva, Switzerland.
P J DoddSchool of Health and Related Research, University of Sheffield, Sheffield, UK.

Funding

Understanding spatial heterogeneity of drug resistant tuberculosisK01AI102944 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI JENKINS, HELEN E. · 2013 to 2017
$627k
NIAID NIH HHS K01 AI102944NIAID NIH HHS K01AI102944World Health Organization 001
6 · The paper itself

Abstract

In the last 5 years, childhood tuberculosis (TB) has received increasing attention from international organisations, national TB programmes and academics. For the first time, a number of different groups are developing techniques to estimate the burden of childhood TB. We review the challenges in diagnosing TB in children and the reasons why cases in children can go unreported. We discuss the importance of an accurate understanding of burden for identifying problems in programme delivery, targeting interventions, monitoring trends, setting targets, allocating resources appropriately and providing strong advocacy. We briefly review the estimates produced by new analytical methods, and outline the reasons for recent improvements in our understanding and potential future directions. We conclude that while innovation, collaboration and better data have improved our understanding of the childhood TB burden, it remains substantially incomplete.

Indexed as

Cost of IllnessChildChild HealthCooperative BehaviorHumansTuberculosisWorld Health Organization

Identifiers

PMID26564535
PMCPMC4708268

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.